Ambiq Micro, Inc. (AMBQ) is an Austin-based fabless semiconductor company whose sub-threshold SPOT technology powers ultra-low-power processors for wearables, medical devices, industrial sensors and edge artificial intelligence applications. Its shares were trading at $41.46 on Friday morning, down $4.14, or 9.08%, from the prior session's close of $45.60. The direction is unambiguously lower, and the decline accelerated as the session progressed after pre-market indications pointed to a softer open near $44.00. No company-specific news release, filing, or brokerage action was identified as the trigger, leaving market participants to attribute the move to continued unwinding of post-earnings positioning and broader caution toward richly valued AI semiconductor names.
No verified news or fundamental catalyst found for Friday's move. Ambiq's most recent material disclosure was its Nov. 10 earnings report, and the subsequent analyst revisions all landed on Nov. 11 — more than a week before today's selloff. With no new information in the tape, the most plausible technical explanation is a liquidity-driven retreat in a stock with a very small float and a well-documented habit of outsized moves.
The shares have roughly 22.3 million shares in public hands and a beta near 3.2, which means relatively modest order flow can produce large percentage swings. The pattern is consistent with speculative, momentum-sensitive trading: in the prior 60 sessions, AMBQ posted an average absolute daily move of about 4.15%, including 15% and 18.7% single-day swings in early November. Friday's decline is roughly 2.2 times that typical daily range — meaningful, but far from extreme by this stock's standards, and similar or larger drops have occurred six times in the past three months. A session that opens weak and grinds lower without news typically reflects profit-taking and position reduction rather than a reassessment of fundamentals.
The broader driver remains the market's recalibration after a spectacular first half of 2026. Ambiq reported third-quarter net sales of $38.1 million, up 110% year over year and its sixth consecutive quarter of sequential growth, with non-GAAP gross margin expanding to 48.7%. Management guided fourth-quarter revenue to $43.5 million–$44.5 million and lifted its full-year 2026 outlook to roughly $140 million, nearly double 2025 levels, while noting that supply constraints still leave some demand unfilled. The company also guided to a fourth-quarter non-GAAP loss of $0.09 to $0.03 per share and flagged rising research and tape-out spending.
Analysts responded by trimming valuations rather than downgrading conviction: Jefferies cut its target to $70 from $90, Northland to $75 from $81, and Roth Capital to $75 from $125, all while maintaining Buy-equivalent ratings. The consensus target now sits near $66.71 across seven analysts. That combination — strong growth, widening losses, and targets being marked down toward market — keeps the shares vulnerable to further de-rating well after the report itself.
Volume in recent sessions has ranged from roughly 300,000 to 900,000 shares against a three-month average near 490,000, so participation has been running above typical levels even before today's slide — a sign that holders have been actively repositioning. Ambiq's decline coincided with weakness in other AI-linked semiconductor and compute listings, which suggests sector-level de-risking rather than an isolated company event.
Technically, the picture has deteriorated. The stock is trading roughly 25% below its 50-day moving average of $55.41 and about 24% below its 200-day average of $54.53, and it has given back most of the ground recovered during the early-November rebound from the $35 area. October alone cost shareholders about 31%, and today's move re-tests the lower end of that range. With short interest equal to roughly seven days of average volume, sharp counter-trend rallies remain a realistic risk alongside further downside.
The score runs from 0, meaning no meaningful news and a move that is entirely normal for the stock, to 100, meaning transformative news paired with an extreme and rare price move. Ambiq scores 12 out of 100.
The news component is weak: no verified company announcement, filing, analyst action or regulatory development coincided with today's decline, and the most recent substantive catalyst was more than a week old. The price component is also modest. At roughly 2.2 times the stock's average absolute daily move, today's slide sits in the low range of unusual, and moves of similar or greater size have occurred six times in the last 60 sessions. Two muted components combine into a low overall reading.
The next scheduled checkpoint is fourth-quarter results, expected in early March, when investors will look for confirmation that the $43.5 million–$44.5 million revenue guide holds and that gross margin near 48% is sustainable amid supply-chain cost pressure. Management's commentary on 2027 capacity, expedite fees and the timing of the Atomiq110 and Apollo340 tape-outs will matter as much as the headline numbers, since both programs carry variable costs that weigh on near-term profitability.
Investors will also track the pace of diversification away from wearables, where the company expects non-wearable revenue to reach only mid-single digits as a share of the total through 2027. Any update on supply availability, customer concentration, or the path to non-GAAP profitability would be more consequential than day-to-day price action. Until then, the combination of a small float, elevated beta and a demanding valuation leaves the shares exposed to sharp swings in either direction.
Tickeron's Trending AI Robots page offers a curated view of the platform's strongest automated trading strategies under current market conditions. Tickeron maintains hundreds of AI trading bots covering thousands of tickers, but only the top performers are surfaced in this section. Bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, allowing users to compare approaches side by side. Explore the page to see which strategies are leading right now and how they are positioned.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for AMBQ moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 2 similar instances when the indicator left oversold territory. In 2 of the 2 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on November 16, 2026. You may want to consider a long position or call options on AMBQ as a result. In 12 of 20 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for AMBQ just turned positive on November 11, 2026. Looking at past instances where AMBQ's MACD turned positive, the stock continued to rise in 8 of 9 cases over the following month. The odds of a continued upward trend are 89%.
Following a +4.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMBQ advanced for three days, in 52 of 70 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
AMBQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 9 of 10 cases where AMBQ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMBQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for AMBQ entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.304) is normal, around the industry mean (5.443). P/E Ratio (-8.688) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (14.771) is also within normal values, averaging (45.795).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. AMBQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMBQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors